Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 10/20 | 0.74 |
| ▸ | CA1 | P00915 | 10/20 | 0.74 |
| ▸ | CA2 | P00918 | 10/20 | 0.74 |
| ▸ | CA4 | P22748 | 10/20 | 0.74 |
| ▸ | CA9 | Q16790 | 10/20 | 0.74 |
| ▸ | PTGER2 | P43116 | 8/20 | 0.71 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13399147 | 1.00 | CA12 (0.74) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5049398 | 0.99 | CA12 (0.73) | CA12CA1CA2CA4CA9 | |
| SCHEMBL4948341 | 0.96 | CA12 (0.80) | CA12CA1CA2CA4CA9 | |
| Hydrochloric Acid SCHEMBL6059996 | 0.95 | CA12 (0.78) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5049400 | 0.92 | PTGER2 (0.72) | CA12CA1CA2CA4CA9 | |
| SCHEMBL4943989 | 0.91 | CA12 (0.80) | CA12CA1CA2CA4CA9 | |
| Hydrochloric Acid SCHEMBL5046767 | 0.90 | CA12 (0.76) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5047904 | 0.89 | CA12 (0.71) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5043167 | 0.89 | PTGER2 (0.64) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5726193 | 0.89 | CA12 (0.66) | CA12CA1CA2CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7442702-B2 | Treatment of bone disorders; carboxy derivatives | PFIZER INC. (US) | 2008-10-28 | — | — | US | disclosed |
| EP-1021410-B1 | PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS | PFIZER (US) | 2006-12-27 | — | — | EP | disclosed |
| US-6498172-B1 | (3-(((4-TERT-BUTYL-BENZYL)-(PYRIDINE-3-SULFONYL)-AMINO)-METHYL) -PHENOXY)-ACETIC ACID OR SALT; TREATING SUCH AS OSTEOPOROSIS | PFIZER INC. | 2002-12-24 | — | — | US | disclosed |